mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.004 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |